Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Current Assets (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Current Assets for 2 consecutive years, with $83.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Current Assets fell 44.2% to $83.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $83.1 million, a 44.2% decrease, with the full-year FY2024 number at $132.4 million, changed N/A from a year prior.
  • Current Assets was $83.1 million for Q3 2025 at Pyxis Oncology, down from $100.0 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $172.4 million in Q1 2024 to a low of $83.1 million in Q3 2025.